Ketogenic diet therapy for epilepsy during pregnancy and lactation: An international survey exploring clinician perspectives.

ABSTRACT:

Objective

Ketogenic diet therapies (KDTs) are increasingly used as a treatment for people with epilepsy of childbearing potential (PWECP) and glucose transporter type 1 deficiency syndrome (Glut1DS). The aim of this study was to collect information on clinical experience with KDT during pregnancy and lactation in these populations.

Methods

Between December 2023 and June 2024, an online survey was widely circulated to healthcare professionals (HCPs) working with PWECP and people with Glut1DS of childbearing potential on KDT. The survey explored KDT use during pregnancy and lactation. Only HCPs working with patients who expressed interest in KDT and who were planning to become pregnant or were already pregnant were invited to complete the survey.

Results

Thirty-five HCP

SUBMITTER: Faltersack K 

PROVIDER: S-EPMC12362179 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature